Urinary and sexual disorders following localised prostate cancer management;Séquelles fonctionnelles de la prise en charge du cancer de prostate localisé

Bulletin du Cancer

Volumn 97, Issue 12, 2010, Pages 1537-1549

  Haab, F ^a   Beley, S ^a   Cornu, J N ^a   Culine, S ^b   Cussenot, O ^a   Hennequin, C ^c  

^a HÔPITAL TENON   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

Brachytherapy; Erectile dysfunction; Prostate cancer; Radiation therapy; Radical prostatectomy; Stress urinary incontinence

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; PHOSPHODIESTERASE V INHIBITOR;

BEHAVIOR THERAPY; CANCER LOCALIZATION; CANCER THERAPY; CLINICAL PRACTICE; CLINICAL RESEARCH; ERECTILE DYSFUNCTION; HUMAN; ORGASM DISORDER; PELVIC FLOOR MUSCLE TRAINING; PENILE FIBROSIS; PENILE RETRACTION; PENIS DISEASE; PENIS PROSTHESIS; PROGNOSIS; PROSTATE CANCER; QUALITY OF LIFE; REVIEW; SEXUAL DYSFUNCTION; URINE INCONTINENCE; UROGENITAL TRACT DISEASE;

EID: 79251495098     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2010.1229     Document Type: Review

References (103)

1. Bossard N, Velten M, Remontet L, Belot A, Maarouf N, Bouvier AM, et al. Survival of cancer patients in France: a population-based study from the Associations of the French Cancer Registries (FRAN-CIM). Eur J Cancer 2007;43:149-60.
2. Glickman L, Godoy G, Lepor H. Changes in continence and erectile function between 2 and 4 years after radical prostatectomy. J Urol 2009;181:731-5.
3. Loughlin KR, Prasad MM. Post-prostatectomy urinary incontinence: a confluence of 3 factors. J Urol 2010;183:871-7.
4. Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008;358:1250-61.
5. Lepor H, Kaci L. The impact of open radical retropubic prostatectomy on continence and lower urinary tract symptoms: a prospective assessment using validated self-administered outcome instruments. J Urol 2004;171:1216-9.
6. Ficazzola MA, Nitti VW. The etiology of post-radical prostatectomy incontinence and correlation of symptoms with urodynamic findings. J Urol 1998;160:1317-20.
7. Majoros A, Bach D, Keszthelyi A, Hamvas A, Romics I. Urinary incontinence and voiding dysfunction after radical retropubic prostatectomy (prospective urodynamic study). Neurourol Urodyn 2006;25:2-7.
8. Hunter KF, Glazener CM, Moore KN. Conservative management for post-prostatectomy urinary incontinence. Cochrane Database Syst Rev 2007: CD001843.
9. Kundu SD, Roehl KA, Eggener SE, Antenor JA, Han M, Catalona WJ. Potency, continence and complications in 3, 477 consecutive radical retropubic prostatectomies. J Urol 2004;172:2227-31.
10. Rogers CG, Su LM, Link RE, Sullivan W, Wagner A, Pavlovich CP. Age stratified functional outcomes after laparoscopic radical prostatectomy. J Urol 2006;176:2448-52.
11. Strasser H, Steinlechner M, Bartsch G. Morphometric analysis of the rhabdosphincter of the male urethra. J Urol 1997;157(S 4):177.
12. Kondo A, Lin TL, Nordling J, Siroky M, Tammela T. Conservative management in men Incontinence: 2nd International Consultation on Incontinence. Plymouth, UK: Health Publications, 2002.
13. Jacobsen NE, Moore KN, Estey E, Voaklander D. Open versus laparoscopic radical prostatectomy: a prospective comparison of postoperative urinary incontinence rates. J Urol 2007;177:615-9.
14. Rodriguez Jr E, Skarecky DW, Ahlering TE. Post-robotic prostatectomy urinary continence: characterization of perfect continence versus occasional dribbling in pad-free men. Urology 2006;67:785-8.
15. Foley CL, Bott SR, Thomas K, Parkinson MC, Kirby RS. A large prostate at radical retropubic prostatectomy does not adversely affect cancer control, continence or potency rates. BJU Int 2003;92:370-4.
16. Abel EJ, Masterson TA, Warner JN, Valentine K, Dechet C. Nerve-sparing prostatectomy and urinary function: a prospective analysis using validated quality-of-life measures. Urology 2009;73:1336-40.
17. Burkhard FC, Kessler TM, Fleischmann A, Thalmann GN, Schumacher M, Studer UE. Nerve sparing open radical retropubic prostatectomy - does it have an impact on urinary continence? J Urol 2006;176:189-95.
18. Stolzenburg JU, Liatsikos EN, Rabenalt R, Do M, Sakelaropoulos G, Horn LC, et al. Nerve sparing endoscopic extraperitoneal radical prostatectomy - effect of puboprostatic ligament preservation on early continence and positive margins. Eur Urol 2006;49:103-12.
19. Ficarra V, Novara G, Artibani W, Cestari A, Galfano A, Graefen M, et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol 2009;55:1037-63.
20. Stone NN, Stock RG. Complications following permanent prostate brachytherapy. Eur Urol 2002;41:427-33.
21. Talcott JA, Clark JA, Stark PC, Mitchell SP. Long-term treatment related complications of brachytherapy for early prostate cancer: a survey of patients previously treated. J Urol 2001;166:494-9.
22. Blaivas JG, Weiss JP, Jones M. The pathophysiology of lower urinary tract symptoms after brachytherapy for prostate cancer. BJU Int 2006;98:1233-7.
23. Grills IS, Martinez AA, Hollander M, Huang R, Goldman K, Chen PY, et al. High-dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low-dose rate palladium seeds. J Urol 2004;171:1098-104.
24. McElveen TL, Waterman FM, Kim H, Dicker AP. Factors predicting for urinary incontinence after prostate brachytherapy. Int J Radiat Oncol Biol Phys 2004;59:1395-404.
25. Chen AB, D'Amico AV, Neville BA, Earle CC. Patient and treatment factors associated with complications after prostate brachytherapy. J Clin Oncol 2006;24:5298-304.
26. Pinkawa M, Fischedick K, Asadpour B, Gagel B, Piroth MD, Nussen S, et al. Toxicity profile with a large prostate volume after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008;70:83-9.
27. Sandhu AS, Zelefsky MJ, Lee HJ, Lombardi D, Fuks Z, Leibel SA. Long-term urinary toxicity after 3-dimensional conformal radiotherapy for prostate cancer in patients with prior history of transurethral resection. Int J Radiat Oncol Biol Phys 2000;48:643-7.
28. Filocamo MT, Li Marzi V, Del Popolo G, Cecconi F, Marzocco M, Tosto A, et al. Effectiveness of early pelvic floor rehabilitation treatment for post-prostatectomy incontinence. Eur Urol 2005;48:734-8.
29. Schlenker B, Gratzke C, Reich O, Schorsch I, Seitz M, Stief CG. Preliminary results on the off-label use of duloxetine for the treatment of stress incontinence after radical prostatectomy or cystectomy. Eur Urol 2006;6:1-4.
30. Marihart S, Brausi M, Rocco B, Herwig R, Anagnostou T, Kaisary A, et al. Prospective randomized study of duloxetine versus anticholinergics versus pelvic floor training alone following radical prostatectomy: impact on timing and magnitude of recovery of continence. Eur Urol Suppl 2006;5:531.
31. Filocamo MT, Li Marzi V, Del Popolo G, Cecconi F, Villari D, Marzocco M, et al. Pharmacologic treatment in post-prostatectomy stress urinary incontinence. Eur Urol 2007;51:1559-64.
32. Gousse AE, Madjar S, Lambert MM. Artificial urinary sphincter for post-radical prostatectomy urinary incontinence: long-term subjective results. J Urol 2001;166:1755-8.
33. Lai HH, Hsu EI, Teh BS. 13 years of experience with artificial urinary sphincter implantation at Baylor College of Medicine. J Urol 2007;177:1021-5.
34. Fulford SC, Sutton C, Bales G. The fate of the "modern" artificial urinary sphincter with a follow-up of more than 10 years. Br J Urol 1997;79:713-6.
35. Walsh IK, Williams SG, Mahendra V, Nambirajan T, Stone AR. Artificial urinary sphincter implantation in the irradiated patient: safety, efficacy and satisfaction. BJU Int 2002;89:364-8.
36. O'Connor RC, Nanigian DK, Patel BN, Guralnick ML, Ellision LM, Stone AR. Artificial urinary sphincter placement in elderly men. Urology 2007;69:126-8.
37. Saussine C, Azzouzi AR, Ballereau C, Desgranchamps F, Devonec M, Fourmarier M, et al. Management of male urinary incontinence after radical prostatectomy (CTMH AFU 2006-3/5): place of periurethral balloon and suburethral tape. Prog Urol 2008;18:23-8.
38. Comiter CV. The male perineal sling: intermediate-term results. Neurourol Urodyn 2005;24:648-53.
39. Giberti C, Gallo F, Schenone M, Cortese P, Ninotta G. The bone anchor suburethral synthetic sling for iatrogenic male incontinence: critical evaluation at a mean 3-year follow-up. J Urol 2009;181:2204-8.
40. Guimarães M, Oliveira R, Pinto R, Soares A, Maia E, Botelho F, et al. Intermediate-term results, up to 4years, of a bone-anchored male perineal sling for treating male stress urinary incontinence after prostate surgery. BJU Int 2009;103:500-4.
41. Mouracade P, Wagner B, Charles T, Lang H, Jacqmin D, Saussine C. Treatment of postoperative male urinary incontinence by bone-anchored male sling. Prog Urol 2008;18:390-4.
42. Cornu JN, Sèbe P, Ciofu C, Peyrat L, Beley S, Tligui M, et al. The advance transobturator male sling for postprostatectomy incontinence: clinical results of a prospective evaluation after a minimum follow-up of 6 months. Eur Urol 2009.
43. Gilling PJ, Bell DF, Wilson LC, Westenberg AM, Reuther R, Fraundorfer MR. An adjustable continence therapy device for treating incontinence after prostatectomy: a minimum 2-year follow-up. BJU Int 2008;102:1426-30.
44. Lebret T, Cour F, Benchetrit J, Grise P, Bernstein J, Delaporte V, et al. Treatment of post-prostatectomy stress urinary incontinence using a minimally invasive adjustable continence balloon device, ProACT: results of a preliminary, multicenter, pilot study. Urology 2008;71:256-60.
45. Westney L, Bevan TR, Palmer L, Cespedes D. Transurethral collagen injections for male intrinsic sphincter deficiency: the University of Texas Houston experience. J Urol 2005;174:994-7.
46. Mitterberger M, Pinggera GM. Functional and histological changes after myoblast injections in the porcine rhabdosphincter. Eur Urol 2007;52:1736-43.
47. Strasser H, Berjukow S, Marksteiner R, Margreiter E, Hering S, Bartsch G. Stem cell therapy for urinary stress incontinence. Exp Gerontol 2004;39:1259.
48. Yiou R, Yoo JJ, Atala A. Restoration of functional motor units in a rat model of sphincter injury by muscle precursor cell autografts. Transplantation 2003;76:1053.
49. Yokoyama T, Yoshimura N, Dhir R, Qu Z, Fraser MO, Kumon H, et al. Persistence and survival of autologous muscle derived cells versus bovine collagen as potential treatment of stress urinary incontinence. J Urol 2001;165:271.
50. Mitterberger M, Marksteiner R. Myoblast and fibroblast therapy for post-prostatectomy urinary incontinence: 1-year follow-up of 63 patients. J Urol 2008;179:226-31.
51. Rosen RC, Cappellrri JC, Gendrano N. The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res 2002;14:226-44.
52. Peneau M, Staerman F. Synthèse thématique. Prog Urol 2006;166:721-30.
53. Podlasek CA, Gonzalez CM, Zelner DJ, Jiang HB, McKenna KE, McVary KT. Analysis of NOS isoform changes in post-radical prostatectomy model of erectile dysfunction. J Urol 2001;13:1-15.
54. Mulhall JP, Slovick R, Hotaling J, Aviv N, Valenzuela R, Waters WB, et al. Erectile dysfunction after radical prostatectomy: hemodynamic profiles and their correlation with the recovery of erectile function. J Urol 2002;167:1371-5.
55. Walsh PC, Marschke P, Ricker D, Burnett AL. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology 2000;55:58.
56. Noldus J, Michl U, Greafen M, Haese A, Hammerer P, Huland H. Patient-reported sexual function after nerve-sparing radical retropubic prostatectomy. Eur Urol 2002;42:118-24.
57. Montorsi F, Luigi G, Strambi L, Da Pozzo L, Nava L, Barbieri L. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomised trial. J Urol 1997;157:1408-10.
58. Hu WL, Hu LQ, Li SW, Zheng XM, Tian BC. Expression of transforming growth factor-beta1 in penile tissue from rats with bilateral cavernosal nerve ablation. BJU Int 2004;94:424-8.
59. Karakiewicz PI, Tanguay S, Kattan MW, Elhilali MM, Aprikian AG. Erectile and urinary dysfunction after radical prostatectomy for prostate cancer in Quebec: a population-based study of 2, 415 men. Eur Urol 2004;46:188-94.
60. Michl UH, Friederich MG, Graefen M, Haese A, Heinzer H, Huland H. Prediction of postoperative sexual function after nerve sparing radical retropubic prostatectomy. J Urol 2006;176:227-31.
61. Bianco Jr FJ, Riedel ER, Begg CB, Kattan MW, Scardino PT. Variations among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters. J Urol 2005;173:2099.
62. Taira AV, Merrick GS, Galbreath RW, Butler WM, Wallner KE, Kurko BS, et al. Erectile function durability following permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2009;75:639-48.
63. Stock RS, Kao J, Stone NN. Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. J Urol 2001;165:436-9.
64. Merrick GS, Wallner K, Butler WM, Lief JH, Sutlief S. Short-term sexual function after prostate brachytherapy. Int J Cancer Radiat Oncol Invest 2001;96:313-9.
65. Merrick GS, Buttler WM, Wallner KE, Lief JH, Anderson RL, Smeiles BJ, et al. The importance of radiation doses to the penile bulb versus crural in the development of postbrachytherapy erectile dysfunction. Int J Radiat Oncol Biol Phys 2002;54:1055-62.
66. Potters L, Torre T, Fearn PA, Leibel SA, Kattan WM. Potency after permanent prostate brachytherapy for localised prostate cancer. Int J Radiat Oncol Biol Phys 2001;50:1235-42. (Pubitemid 32727801)
67. Merrick GS, Butler WM, Dorsey AT, Lief JH, Donzella JG. A comparison of radiation dose to the neurovascular bundles in men with an without prostate brachytherapy-induced erectile dysfunction. Int J Radiat Oncol Biol Phys 2000;48:1069-74.
68. Kiteley R, Lee W, Deguzman A, Mirzaei M, McCullough D. Radiation dose to the neurovascular bundles or penile bulb does not predict erectile dysfunction after prostate brachytherapy. Brachytherapy 2002;1:90-4.
69. van der Wielen GJ, Mulhall JP, Incrocci L. Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: a critical review. Radiother Oncol 2007;84:107-13.
70. Incrocci L, Slob AK, Levendag PC. Sexual (dys) function after radiotherapy for prostate cancer: a review. Int J Radiat Oncol Biol Phys 2002;52:681-93.
71. Burnett AL, Aus G, Canby-Hagino ED, Cookson MS, D'Amico AV, Dmochowski RR, et al. Erectile function outcome reporting after clinically localized prostate cancer treatment; American Urological Association Prostate Cancer Guideline Update Panel. J Urol 2007;178:597-601.
72. Fransson P, Widmark A. Self-assessed sexual function after pelvic irradiation for prostate carcinoma. Comparison with an agematched control group. Cancer 1996;78:1066-78.
73. Pinkawa M, Gagel B, Piroth MD, Fischedick K, Asadpour B, Kehl M, et al. Erectile dysfunction after external beam radiotherapy for prostate cancer. Eur Urol 2009;55:227-34.
74. Stanford JL, Feng Z, Hamilton AS. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the prostate cancer outcomes study. JAMA 2000;283:354-60.
75. Kao J, Turian J, Meyers A, Hamilton RJ, Smith B, Vijayakumar S, et al. Sparing of the penile bulb and the proximal penile structures with intensity-modulated radiation therapy for prostate cancer. Br J Radiol 2004;77:129-36.
76. Zelefsky MJ, McKee AB, Lee H. Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate. Urology 1999;53:775-8.
77. Zelefsky MJ, Eid JF. Elucidating the etiology of erectile dysfunction after definitive therapy for prostatic cancer. Int J Radiat Oncol Biol Phys 1998;40:129.
78. Litwin MS, Flanders SC, Pasta DJ, Stoddard ML, Lubeck DP, Henning JM. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE, Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 1999;54:503-8.
79. Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. J Urol 2007;177:2151-6.
80. Robinson J, Mortiz S, Fung T. Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma. Int J Radiat Oncol Biol Phys 2002;54:1063-8.
81. Walsh PC, Marschke P, Ricker D, Burnett AL. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology 2000;55:58-61. (Pubitemid 30050758)
82. Menon M, Tewari A, Baize B, Guillonneau B, Vallancien G. Prospective comparison of radical retropubic prostatectomy and robot-assisted anatomic prostatectomy: the Vattikuti Urology Institute experience. Urology 2002;60:864.
83. Porpiglia F, Ragni F, Terrone C, Renard J, Musso F, Grande S, et al. Is laparoscopic unilateral sural nerve grafting during radical prostatectomy effective in retaining sexual potency? BJU Int 2005;95:1267-72.
84. Davis JW, Chang DW, Chevray P, Wang R, Shen Y, Wen S, et al. Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancer. Eur Urol 2009;55:1135-43.
85. Connolly SS, Yoo JJ, Abouheba M, Soker S, McDougal WS, Atala A. Cavernous nerve regeneration using acellular nerve grafts. World J Urol 2008;26:333-9.
86. Montorsi F, McCullough A. Efficacy of sildenafil citrate in men with erectile dysfunction following radical prostatectomy: a systematic review of clinical data. J Sex Med 2005;2:658.
87. Montorsi F, Brock G, Lee J, Shapiro J, Van Poppel H, Graefen M, et al. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008;54:924-31.
88. Zagaja GP, Mhoon DA, Aikens JE, Brendler CB. Sildenafil in the treatment of erectile dysfunction after radical prostatectomy. Urology 2000;56:631-4.
89. Schwartz EJ, Wong P, Graydon RJ. Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol 2004;171:771-4.
90. Lysiak JJ, Yang SK, Klausner AP, Son H, Tuttle JB, Steers WD. Tadalafil increases Akt and extracellular signal-regulated kinase 1/2 activation, and prevents apoptotic cell death in the penis following denervation. J Urol 2008;179:779-85.
91. Kovanecz I, Rambhatla A, Ferrini MG, Vernet D, Sanchez S, Rajfer J, et al. Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection. BJU Int 2008;101:203-10.
92. Ohebshalom M, Parker M, Guhring P, Mulhall JP. The efficacy of sildenafil citrate following radiation therapy for prostate cancer: temporal considerations. J Urol 2005;174:258-62.
93. Schiff JD, Bar-Chama N, Cesaretti J, Stock R. Early use of a phosphodiesterase inhibitor after brachytherapy restores and preserves erectile function. BJU Int 2006;98:1255-8.
94. Vale J. Erectile dysfunction following radical therapy for prostate cancer. Radiother Oncol 2000;57:301-5.
95. Incrocci L, Slagter C, Slob AK, Hop WC. A randomized, double blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma. Int J Radiat Oncol Biol Phys 2006;66:439-44.
96. Lee IH, Sadetsky N, Carroll PR, Sandler HM. The impact of treatment choice for localized prostate cancer on response to phosphodiesterase inhibitors. J Urol 2008;179:1072-6.
97. Teloken PE, Parker M, Mohideen N, Mulhall JP. Predictors of response to sildenafil citrate following radiation therapy for prostate cancer. J Sex Med 2009;6:1135-40.
98. Köhler TS, Pedro R, Hendlin K, Utz W, Ugarte R, Reddy P, et al. A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy. BJU Int 2007;100:858-62.
99. Montorsi F, Nathan HP, McCullough A, Brock GB, Broderick G, Ahuja S, et al. Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double blind, placebo controlled trial. J Urol 2004;172:1036-41.
100. Mulhall JP, Land S, Parker M, Waters WB, Flanigan RC. The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. J Sex Med 2004;1(S 1): abstract MP82.
101. Titta M, Tavolini IM, Moro FD, Cisternino A, Bassi P. Sexual counseling improved erectile rehabilitation after non-nerve-sparing radical retropubic prostatectomy or cystectomy - results of a randomized prospective study. J Sex Med 2006;3:267-73.
102. Menard J, Tremeaux J, Faix A, Staerman F. Prothèses péniennes: évaluation multicentrique des pratiques: résultats d'une série de 282 implantations. Prog Urol 2007;17:229-34.
103. Montorsi F, Guazzoni G, Strambi LF, Da Pozzo LF, Nava L, Barbieri L, et al. Recovery of spontaneous erectile function after nerve sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective randomized trial. J Urol 1997;158:1408-10.